Helicobacter pylori: Physiology and Genetics (Edited by: Mobley H

OSI-027 ic50 Helicobacter pylori: Physiology and Genetics (Edited by: Mobley HLT, Mendz GL, Hazell SL). Herndon, VA: ASM Press 2001, 81–95. 25. Albertson N, Wenngren I, Sjostrom JE: Growth and survival of Helicobacter pylori

in defined medium and susceptibility to Brij 78. J Clin Microbiol 1998,36(5):1232–1235.PubMed 26. Testerman TL, McGee DJ, Mobley HL:Helicobacter pylori growth and urease detection in the chemically defined medium Ham’s F-12 nutrient mixture. J Clin Microbiol 2001,39(11):3842–3850.CrossRefPubMed 27. Trampenau C, Muller KD: Affinity of Helicobacter pylori to cholesterol and other steroids. Microbes Infect 2003,5(1):13–17.CrossRefPubMed 28. Razin S: Cholesterol incorporation into bacterial membranes. J Bacteriol 1975,124(1):570–572.PubMed 29. Ben-Menachem G, Kubler-Kielb J, Coxon B, Yergey A, Schneerson R: A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Torin 2 supplier Proc Natl Acad Sci USA 2003,100(13):7913–7918.CrossRefPubMed

30. Noh DO, Kim SH, Gilliland SE: Incorporation of cholesterol into the cellular membrane of Lactobacillus acidophilus ATCC 43121. J Dairy Sci 1997,80(12):3107–3113.CrossRefPubMed selleck inhibitor 31. Razin S: The cell membrane of mycoplasma. Ann N Y Acad Sci 1967,143(1):115–129.CrossRefPubMed 32. Rodwell AW, Abbot A: The function of glycerol, cholesterol and long-chain fatty acids in the nutrition of Mycoplasma mycoides. J Gen Microbiol 1961, 25:201–214.PubMed 33. Haque M, Hirai Y, Yokota K, Mori N, Jahan I, Ito H, Hotta H, Yano I, Kanemasa Y, Oguma K: Lipid profile of Helicobacter spp.: presence of cholesteryl glucoside as a characteristic feature. J Bacteriol 1996,178(7):2065–2070.PubMed 34. Hirai Y, Haque M, Yoshida T, Yokota K, Yasuda T, Oguma K: Unique cholesteryl glucosides in Helicobacter pylori : composition and structural analysis. J

3-mercaptopyruvate sulfurtransferase Bacteriol 1995,177(18):5327–5333.PubMed 35. Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, Zahringer U, Mollenkopf HJ, Heinz E, Meyer TF: Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006,12(9):1030–1038.CrossRefPubMed 36. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995,63(1):94–98.PubMed 37. Lee A, O’Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997,112(4):1386–1397.CrossRefPubMed 38. Linstead D: New defined and semi-defined media for cultivation of the flagellate Trichomonas vaginalis. Parasitology 1981,83(Pt 1):125–137.CrossRefPubMed 39. Testerman TL, Conn PB, Mobley HL, McGee DJ: Nutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media.

Comments are closed.